TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $459,000 | +165.3% | 56,675 | +32.6% | 0.15% | +104.1% |
Q1 2020 | $173,000 | +3360.0% | 42,750 | +144.3% | 0.07% | +7300.0% |
Q4 2019 | $5,000 | -28.6% | 17,500 | -32.7% | 0.00% | -50.0% |
Q3 2019 | $7,000 | -36.4% | 26,000 | -22.4% | 0.00% | -33.3% |
Q2 2019 | $11,000 | – | 33,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |